A J Mayorga1, I Lucki. 1. Department of Psychiatry, 415 Curie Boulevard, Room 538A, Clinical Research Building, University of Pennsylvania, Philadelphia, PA 19104-6140, USA.
Abstract
RATIONALE: The C57BL/6 is one of the most widely used mouse strains in behavioral, pharmacological, and genetic research but little is known about their response on tests for antidepressant drugs. OBJECTIVES: The behavior of C57BL/6 mice, and mice from other strains, was examined in the tail suspension test (TST), a common behavioral test used for the screening of antidepressant compounds. METHODS: C57BL/6J mice from the Jackson Laboratory, C57BL/6N mice from Harlan, A/J, 129-SV-ter and DBA/2 mice were tested under baseline conditions in the TST. RESULTS: The majority of the C57BL/6 mice from the Jackson Laboratory tested in this paradigm (70%) climbed up their tails during the 6-min test session. C57BL/6 mice obtained from Harlan (35%) also demonstrated this climbing behavior, suggesting that it is not specific to mice from a particular supplier. Other strains (A/J 18%), 129-SV-ter (0%) and DBA/2 (0%) mice) showed less propensity for tail climbing. CONCLUSIONS: The occurrence of this behavior is an important consideration when testing antidepressant drugs or the effects of stress using the TST with inbred mouse strains, especially those from the C57BL/6 strain.
RATIONALE: The C57BL/6 is one of the most widely used mouse strains in behavioral, pharmacological, and genetic research but little is known about their response on tests for antidepressant drugs. OBJECTIVES: The behavior of C57BL/6 mice, and mice from other strains, was examined in the tail suspension test (TST), a common behavioral test used for the screening of antidepressant compounds. METHODS: C57BL/6J mice from the Jackson Laboratory, C57BL/6N mice from Harlan, A/J, 129-SV-ter and DBA/2 mice were tested under baseline conditions in the TST. RESULTS: The majority of the C57BL/6 mice from the Jackson Laboratory tested in this paradigm (70%) climbed up their tails during the 6-min test session. C57BL/6 mice obtained from Harlan (35%) also demonstrated this climbing behavior, suggesting that it is not specific to mice from a particular supplier. Other strains (A/J 18%), 129-SV-ter (0%) and DBA/2 (0%) mice) showed less propensity for tail climbing. CONCLUSIONS: The occurrence of this behavior is an important consideration when testing antidepressant drugs or the effects of stress using the TST with inbred mouse strains, especially those from the C57BL/6 strain.
Authors: David T Dao; Pamela Belmonte Mahon; Xiang Cai; Colleen E Kovacsics; Robert A Blackwell; Michal Arad; Jianxin Shi; Peter P Zandi; Patricio O'Donnell; James A Knowles; Myrna M Weissman; William Coryell; William A Scheftner; William B Lawson; Douglas F Levinson; Scott M Thompson; James B Potash; Todd D Gould Journal: Biol Psychiatry Date: 2010-08-17 Impact factor: 13.382
Authors: Donald M Lamkin; Susan K Lutgendorf; David Lubaroff; Anil K Sood; Terry G Beltz; Alan Kim Johnson Journal: Brain Behav Immun Date: 2010-12-21 Impact factor: 7.217
Authors: Steven G Kinsey; Michael T Bailey; John F Sheridan; David A Padgett; Ronit Avitsur Journal: Brain Behav Immun Date: 2006-12-18 Impact factor: 7.217
Authors: Adem Can; David T Dao; Chantelle E Terrillion; Sean C Piantadosi; Shambhu Bhat; Todd D Gould Journal: J Vis Exp Date: 2012-01-28 Impact factor: 1.355
Authors: Camron D Bryant; Nanci N Zhang; Greta Sokoloff; Michael S Fanselow; Helena S Ennes; Abraham A Palmer; James A McRoberts Journal: J Neurogenet Date: 2008 Impact factor: 1.250
Authors: O Malkesman; D R Austin; T Tragon; I D Henter; J C Reed; M Pellecchia; G Chen; H K Manji Journal: Mol Psychiatry Date: 2011-07-05 Impact factor: 15.992
Authors: Delaney K Fischer; Richard C Rice; Arlene Martinez Rivera; Mary Donohoe; Anjali M Rajadhyaksha Journal: Behav Brain Res Date: 2017-05-26 Impact factor: 3.332
Authors: Darrick T Balu; Jill R Turner; Bethany R Brookshire; Tiffany E Hill-Smith; Julie A Blendy; Irwin Lucki Journal: Neuropharmacology Date: 2012-12-06 Impact factor: 5.250
Authors: Mariana Angoa-Pérez; Michael J Kane; Denise I Briggs; Nieves Herrera-Mundo; Catherine E Sykes; Dina M Francescutti; Donald M Kuhn Journal: ACS Chem Neurosci Date: 2014-08-12 Impact factor: 4.418
Authors: Todd D Gould; Kelley C O'Donnell; Eliot R Dow; Jing Du; Guang Chen; Husseini K Manji Journal: Neuropharmacology Date: 2007-11-17 Impact factor: 5.250